📣 Neola Medical Reports Positive Safety Results from First Clinical Pilot Study and Advances Towards Next Phase of Clinical Development
💡 Read more in the press release here: https://t.co/ZwbLQXdQ8E
Redeye Interview: Neola Medical Q4 2025 with CEO Hanna Sjöström
🎥 Watch the full interview here: https://t.co/ySrcuYgCDO
💡 Access additional insights from Redeye here: https://t.co/e9A5n5vQHf
Did you miss Neola Medical’s Q4 report presentation hosted by Investor Studios?
🎥 Watch the report presentation and stay for the Q&A session here: https://t.co/Sv08fypQzJ
📣 Neola Medical today released the Q4 report of 2025! 📘👶🏻 – Advancing IP Protection as a Core Strategic Asset across Key Markets
💡 Read the entire press release and the report at our website: https://t.co/YkrF8pRJl2
📣 We hereby invite you to a live presentation of our Q4 report of 2025!
🗓️ February 12, 2026, at 11:00 CET (11.00)
🎥 Watch the presentation here: https://t.co/Sv08fypQzJ
💡Read more in the press release here: https://t.co/LHYMw8I5jj
📣 Today we released the winter edition of Neola Medical’s Investor Letter 2025
💡 Read the entire press release and the investor letter here: https://t.co/VDGXU9wPOH
Last week Neola Medical had the opportunity to visit the Neonatal Intensive Care Unit (NICU) at Stanford Medicine Children's Health in Palo Alto, USA.
We were pleased to meet with Dr. Valerie Chock and Impact1 co-director Janene Fuerch and gain valuable insights.
📣 Neola Medical expands leadership team with appointment of Director Disposable Product Development
💡 Read the press release here: https://t.co/LQi71eWHLG
🚀 Explore our new website! 🚀
We’ve launched a new version of our website to make it easier to follow our progress, learn about our technology, and access investor information. We hope you will appreciate the new design!
🔗 Visit our website at https://t.co/fI1BnC34Ow ✨
📣 Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market 🇺🇸
💡 Read more in the press release here: https://t.co/ULgbzzZLgQ
🌟 Visiting the U.S. Study Site 🇺🇸
Neola Medical recently visited the Neonatal Intensive Care Unit (NICU) at Children’s Regional Hospital at Cooper University Health Care in Camden, New Jersey — first study site for our planned clinical study on preterm born babies in the U.S.
📣 Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements
💡 Read more in the press release here: https://t.co/PVAMNMRxSn
📣 Neola Medical Strengthens Global IP Portfolio with New Patents Granted in both the U.S. and China for Medical Device Neola®
💡 Read more in the press release here: https://t.co/YnySmSnTNs
📣 Today we released the autumn edition of Neola Medical’s Investor Letter 2025
💡 Read the entire press release and the investor letter here: https://t.co/JCnti6dz2w
🚀 CEO Hanna Sjöström invited as panelist at Stanford Impact1 CEO Summit in Austin, Texas 🇺🇸
💡Learn more and read the entire article about the exclusive particiapation at Stanford Impact1 here: https://t.co/B48tqOcmSj
📣 Neola Medical granted European patent enabling lung monitoring beyond preterm born babies 🇪🇺
💡 Read more in the press release here: https://t.co/KZM5zvtBo2